Slovenia is taking a major step toward legalizing medical cannabis with a new bill introduced by members of the Freedom Movement and The Left parties. The proposed legislation would allow the use of cannabis strictly for medical and scientific purposes, marking a significant shift in the country’s drug policy.
A Focus on Safety and Access
The bill aims to protect patients from unregulated cannabis products often found on the black market by ensuring access to quality-controlled medical cannabis. It also seeks to create a stable supply system and close existing regulatory gaps.
Under the proposal, the Public Agency for Medicines and Medical Devices would be responsible for overseeing licensing, production, and distribution. The Ministry of Health would handle permits related to scientific research, creating a two-tier regulatory framework to support both patient care and scientific innovation.
Supporting Patients with Serious Illnesses
Lawmakers backing the bill emphasize its potential to improve treatment options for patients with severe conditions like multiple sclerosis, epilepsy, and cancer. By allowing doctors to prescribe cannabis similarly to other medications, Slovenia hopes to ensure consistency and quality in medical cannabis products.
MP Nataša Sukić, a supporter of the bill, highlighted that integrating cannabis into the national healthcare system could improve quality of life for many patients.
Economic Potential and International Outlook
Beyond healthcare, the legislation could also open economic opportunities. Sarah Žibrat of the Freedom Movement noted that legalizing medical cannabis could pave the way for international exports of Slovenian-grown cannabis products.
The proposed system is designed to avoid monopolies, instead promoting a competitive environment where qualified growers and researchers can participate under strict quality controls.
A Shift Away from Prohibition
Reform advocates argue that prohibition has fueled the black market rather than stopping it. Legalizing medical cannabis, they say, brings transparency, improves public health, and reduces access to potentially dangerous unregulated products.
Lawmakers supporting the change see it as a necessary evolution—one that aligns Slovenia with other progressive European countries like Germany, Luxembourg, and the Netherlands, all of which are exploring more open cannabis policies.
Looking Ahead
Slovenia currently permits some cannabinoid-based medications, but full access to medical marijuana remains restricted. If passed, the new legislation would mark a major policy shift. Lawmakers hope it will be a model for future reforms, including potential discussions around home cultivation and decriminalization of adult use.
As the debate continues, optimism is growing among supporters who view the bill as a balanced approach supporting medical needs, economic growth, and responsible regulation, all while addressing the risks associated with unregulated cannabis use.
Rita Ferreira
Rita is a seasoned writer with over five years of experience, having worked with globally renowned platforms, including Forbes and Miister CBD. Her deep knowledge of hemp-related businesses and passion for delivering accurate and concise information distinguish her in the industry. Rita's contributions empower individuals and companies to navigate the complexities of the cannabis world, and her work remains a valuable resource for those seeking a deeper understanding of its potential.
